Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-08-23 4:30 pm Purchase |
2021-08-11 | 13G | Aerpio Pharmaceuticals, Inc. ARPO |
RA Capital Management, L.P. | 165,749 5.220% |
60,762 (+57.88%) |
Filing History |
| 2021-08-19 4:30 pm Purchase |
2021-08-09 | 13D | Climb Bio, Inc. CLYM |
RA Capital Management, L.P. | 13,151,959 50.000% |
13,151,959 (New Position) |
Filing History |
| 2021-08-18 5:30 pm Purchase |
2009-02-28 | 13D | Wave Life Sciences Ltd. WVE |
RA Capital Management, L.P. | 7,823,207 15.390% |
48,000 (+0.62%) |
Filing History |
| 2021-08-16 4:32 pm Unchanged |
2021-08-16 | 13G | Adverum Biotechnologies, Inc. ADVM |
RA Capital Management, L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-08-13 4:31 pm Purchase |
2021-08-03 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
RA Capital Management, L.P. | 1,606,859 5.600% |
1,606,859 (New Position) |
Filing History |
| 2021-08-13 4:30 pm Purchase |
2021-08-03 | 13G | RxSight, Inc. RXST |
RA Capital Management, L.P. | 3,052,796 11.100% |
3,052,796 (New Position) |
Filing History |
| 2021-08-12 4:30 pm Purchase |
2021-08-02 | 13D | Icosavax, Inc. ICVX |
RA Capital Management, L.P. | 5,779,347 14.700% |
5,779,347 (New Position) |
Filing History |
| 2021-08-09 5:17 pm Purchase |
2021-07-30 | 13G | DA32 Life Science Tech Acquisition Corp. DALS |
RA Capital Management, L.P. | 1,500,000 7.300% |
1,500,000 (New Position) |
Filing History |
| 2021-08-09 4:32 pm Purchase |
2021-07-30 | 13G | Tenaya Therapeutics, Inc. TNYA |
RA Capital Management, L.P. | 3,551,508 8.600% |
3,551,508 (New Position) |
Filing History |
| 2021-08-06 4:30 pm Purchase |
2021-07-27 | 13D | Cytek Biosciences, Inc. CTKB |
RA Capital Management, L.P. | 9,607,028 7.200% |
9,607,028 (New Position) |
Filing History |
| 2021-07-28 4:30 pm Purchase |
2021-07-20 | 13G | TScan Therapeutics, Inc. TCRX |
RA Capital Management, L.P. | 1,255,317 6.700% |
1,255,317 (New Position) |
Filing History |
| 2021-07-23 4:30 pm Purchase |
2021-07-13 | 13G | ARYA Sciences Acquisition Corp V ARYE |
RA Capital Management, L.P. | 1,000,000 6.500% |
1,000,000 (New Position) |
Filing History |
| 2021-07-20 4:31 pm Purchase |
2021-07-20 | 13G | POINT Biopharma Global Inc. PNT |
RA Capital Management, L.P. | 8,856,018 9.800% |
8,856,018 (New Position) |
Filing History |
| 2021-07-16 4:30 pm Purchase |
2021-07-06 | 13D | Acumen Pharmaceuticals, Inc. ABOS |
RA Capital Management, L.P. | 9,770,773 25.300% |
9,770,773 (New Position) |
Filing History |
| 2021-07-12 5:13 pm Purchase |
2021-07-02 | 13D | Aerovate Therapeutics, Inc. AVTE |
RA Capital Management, L.P. | 8,263,982 33.900% |
8,263,982 (New Position) |
Filing History |
| 2021-07-12 4:30 pm Purchase |
2021-06-30 | 13G | Aerpio Pharmaceuticals, Inc. ARPO |
RA Capital Management, L.P. | 104,987 3.300% |
104,987 (New Position) |
Filing History |
| 2021-07-09 4:31 pm Purchase |
2021-06-29 | 13G | GH Research PLC GHRS |
RA Capital Management, L.P. | 2,978,955 5.900% |
2,978,955 (New Position) |
Filing History |
| 2021-06-30 4:33 pm Purchase |
2021-06-23 | 13G | Entera Bio Ltd. ENTX |
RA Capital Management, L.P. | 2,353,000 9.900% |
2,353,000 (New Position) |
Filing History |
| 2021-06-30 4:32 pm Purchase |
2021-06-24 | 13D | Therapeutics Acquisition Corp. RACA |
RA Capital Management, L.P. | 1,098,318 7.800% |
1,098,318 (New Position) |
Filing History |
| 2021-06-29 4:33 pm Purchase |
2021-06-22 | 13G | CYTEIR THERAPEUTICS INC CYTT |
RA Capital Management, L.P. | 3,247,117 9.400% |
3,247,117 (New Position) |
Filing History |